Pfizer's Centers for Therapeutic Innovation (CTI) is a unique joint drug discovery model focused on collaborating with leading academic medical centers to rapidly translate novel target opportunities into new medicines.CTI collaborations may include:
- Funded project-related research
- Hands-on collaboration from dedicated Pfizer drug-development experts
- Access to scientific/technological expertise and infrastructure at Pfizer
- Potential for financial incentives in the form of milestone and royalty payments
- Flexible publishing rights
- Opportunity for involvement in CTI’s Foundation collaborations
Pre-proposal Submission Process
A non-confidential 2-3 page overview of the target, mechanism of action, evidence for disease linkage, and the proposed therapeutic drug, is to be submitted to the Faculty Business Development team by Monday 29 April 2019 via email to mnhs.busdev@monash.edu. At a high level, the pre-proposal should suggest how the therapeutic hypothesis could be tested in the clinic.
For more information on this opportunity, please refer to the flyer or contact mnhs.busdev@monash.edu.
No comments:
Post a Comment